Electrophysiological and clinical correlates of corpus callosum atrophy in patients with multiple sclerosis

Neurological Research

Volumn 32, Issue 8, 2010, Pages 886-890

  Kale, N ^a   Agaoglu, J ^b,c   Tanik, O ^b,c  

^a MAYO CLINIC   (United States)

^b OKMEYDANI TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Department of Neurology   (Turkey)

Author keywords

CORPUS CALLOSUM ATROPHY; EDSS; MEP; MRI; MULTIPLE SCLEROSIS; TMS

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS CALLOSUM; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROPHYSIOLOGY; EVOKED MUSCLE RESPONSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FREQUENCY ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; ATROPHY; COHORT STUDIES; CORPUS CALLOSUM; ELECTROPHYSIOLOGICAL PHENOMENA; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77956574016     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164109X12445616596526     Document Type: Article

References (28)

1. Bruck W. Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis. J Neurol 2005; 252 (Suppl. 5): v10-v15
2. Lassmann H. The pathology of multiple sclerosis and its evolution. Philos Trans R Soc Lond B Biol Sci 1999; 354: 1635-1640
3. Lassmann H, Bruck W, Lucchinetti CF, et al. The immunopathology of multiple sclerosis: An overview. Brain Pathol 2007; 17: 210-218
4. Lucchinetti C, Brück W, Parisi J, et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707-717.
5. Lucchinetti CF, Parisi J, Bruck W. The pathology of multiple sclerosis. Neurol Clin 2005; 23: 77-105
6. Jokinen H, et al. Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: The LADIS Study. J Neurol Neurosurg Psychiatry 2007; 78: 491-496
7. Nauta JJ, et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: Statistical power of parallel-groups and crossover designs. J Neurol Sci 1994; 122: 6-14
8. Fierro B, Salemi G, Brighina F, et al. A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis. Acta Neurol Scand 2002; 105: 152-157
9. Fuhr P, Kappos L. Evoked potentials for evaluation of multiple sclerosis. Clin Neurophysiol 2001; 112: 2185-2189
10. Leocani L, Rovaris M, Boneschi FM, et al. Multimodal evoked potentials to assess the evolution of multiple sclerosis: A longitudinal study. J Neurol Neurosurg Psychiatry 2006; 77: 1030-1035
11. Audoin B, Ibarrola D, Malikova I, et al. Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis -a two-year longitudinal MRI/MRSI study of corpus callosum. Mult Scler 2007; 13: 41-51
12. Barkhof F, Scheltens P, Frequin ST, et al. Relapsing-remitting multiple sclerosis: Sequential enhanced MR imaging vs clinical findings in determining disease activity. AJR Am J Roentgenol 1992; 159: 1041-1047
13. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-127
14. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: A consensus approach. Mult Scler 2008; 14: 1157-1174
15. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988; 38: 180-185
16. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231
17. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452
18. Paolillo A, Pozzilli C, Gasperini C, et al. Brain atrophy in relapsing-remitting multiple sclerosis: relationship with black holes, disease duration and clinical disability. J Neurol Sci 2000; 174: 85-91
19. Pelletier J, Suchet L, Witjas T, et al. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Arch Neurol 2001; 58: 105-111
20. Simon JH, Jacobs LD, Campion MK, et al. A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology 1999; 53: 139-148
21. Furby J, Hayton T, Anderson V, et al. Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis. Mult Scler 2008; 14: 1068-1075
22. Barkhof FJ, Elton M, Lindeboom J, et al. Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study. J Neurol 1998; 245: 153-158
23. Figueira FF, Santos VS, Figueira GM, et al. Corpus callosum index: A practical method for long-term follow-up in multiple sclerosis. Arq Neuropsiquiatr 2007; 65: 931-935
24. Rashid W, Davies GR, Chard DT, et al. Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: A two-year longitudinal study. Mult Scler 2007; 13: 178-185
25. Oh J, Henry RG, Genain C, et al. Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging. J Neurol Neurosurg Psychiatry 2004; 75: 1281-1286
26. Kidd D, Thompson PD, Day BL, et al. Central motor conduction time in progressive multiple sclerosis. Correlations with MRI and disease activity. Brain 1998; 121: 1109-1116
27. Kjaer M. Evoked potentials. With special reference to the diagnostic value in multiple sclerosis. Acta Neurol Scand 1983; 67: 67-89
28. Sahota P, Prabhakar S, Lal V, et al. Transcranial magnetic stimulation: Role in the evaluation of disability in multiple sclerosis. Neurol India 2005; 53: 197-201